no statement of use filed
on 26 Sep 2022
Last Applicant/ Owned by
320 Soquel Way
Sunnyvale
CA
94085
Serial Number
88332329 filed on 08th Mar 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; biotechnology preparations in the nature of stems cells derived from a culture of bone marrow cells for use in cell therapy for the prevention, management, diagnosis and treatment of connective tissue and ischemic cardiovascular Read More
Pharmaceutical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; biotechnology preparations in the nature of stems cells derived from a culture of bone marrow cells for use in cell therapy for the prevention, management, diagnosis and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; medical preparations for the prevention, management, and treatment of connective tissue and ischemic cardiovascular disease and autoimmune diseases and indications; human allograft tissue; human tissue for transplantation or implantation, medical and surgical purposes; human cells, including stem cells, and pharmaceutical preparations all used for the treatment, reconstruction and repair of damaged tissue
No 88332329
No Service/Collective Mark
No 29181-TM1005
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Sep 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
26th Sep 2022 | ABANDONMENT - NO USE STATEMENT FILED |
25th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
24th Feb 2022 | SOU EXTENSION 5 GRANTED |
24th Feb 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
17th Feb 2022 | SOU EXTENSION 5 FILED |
17th Feb 2022 | TEAS EXTENSION RECEIVED |
24th Aug 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
20th Aug 2021 | SOU EXTENSION 4 GRANTED |
20th Aug 2021 | SOU EXTENSION 4 FILED |